• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE Back to Search Results
Model Number F1034
Device Problems Fracture (1260); Detachment of Device or Device Component (2907)
Patient Problems Hepatitis (1897); No Consequences Or Impact To Patient (2199)
Event Date 07/15/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation of the returned optowire iii showed that the guidewire was fractured at 30cm from its distal end, in the proximal joint of the shaft portion of the device.The combined length of the proximal and distal fragments confirmed that no part was left behind in the patient.The characteristics of the fracture indicated that the guidewire broke from fatigue.The guidewire would have failed from repeated pull/push; the guidewire displayed no sign of excessive torsion or kink at the fracture point.No evidence of manufacturing issue or material defect was observed.Based on the narrative and results from investigation, difficult insertion into the tortuous and calcified coronary lead to the fracture by fatigue of the guidewire's shaft.The cause of the failure is likely related to the usage of the device beyond the recommendations provided in the instructions for use ifu).Review of device history record confirmed that the optowire lot was released per specifications.The investigation did not identify any new risk.The risks associated with the event are disclosed in the optowire iii instructions for use (ifu):if resistance occurs and the cause of resistance cannot be determined, do not move or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.Optowire should be manipulated only under fluoroscopy.Care should be taken when manipulating a guidewire inside a vessel during device placement and removal.Observe optowire movement in the vessels.Before an optowire is moved or torqued, the tip movement should be examined under fluoroscopy.Do not torque an optowire without observing corresponding movement of the tip; otherwise, vessel trauma may occur.Never advance an optowire against resistance without first determining the reason for the resistance under fluoroscopy.Excessive force against resistance may result in damage to the wire and/or to the vessel.If resistance occurs and the cause of resistance cannot be determined, do not move or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.Do not use the optowire if any portion of the device or packaging appears damaged, if any portion of the sterile pouch has been opened or if product is expired.A corrective action is already open.No additional action intended as a result of the incident.(b)(4).
 
Event Description
4f angiocath was used together with fractured owiii.Equalize was done without problem.Coronary was so tortuous and calcified that the doctor noted difficulty to insert the owiii to lesion.The doctor gave up to insert the wire, but it fractured at around 300mm from tip when withdrawing.The doctor said that he torqued the wire when to insert the wire.The fragment was retrieved by snare.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTOWIRE III
Type of Device
CORONARY PRESSURE GUIDEWIRE
Manufacturer (Section D)
OPSENS
750 blvd parc technologique
quebec, quebec G1P 4 S3
CA  G1P 4S3
Manufacturer Contact
samuel magnan
750 blvd parc technologique
quebec, quebec G1P 4-S3
CA   G1P 4S3
MDR Report Key10408122
MDR Text Key249162820
Report Number3008061490-2020-00003
Device Sequence Number1
Product Code DXO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K191907
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial
Report Date 07/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberF1034
Device Lot NumberOW-2035D
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/14/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/16/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-